Economic Evaluation of Oral Treatments for Neuropathic Pain
- 28 February 2006
- journal article
- Published by Elsevier in The Journal of Pain
- Vol. 7 (2) , 119-128
- https://doi.org/10.1016/j.jpain.2005.09.004
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- What decline in pain intensity is meaningful to patients with acute pain?Published by Wolters Kluwer Health ,2003
- Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility scoreSupportive Care in Cancer, 2002
- Peripheral neuropathic pain—a multidimensional burden for patientsEuropean journal of pain, 2001
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePAIN®, 2001
- Antidepressants and Anticonvulsants for Diabetic Neuropathy and Postherpetic Neuralgia: A Quantitative Systematic ReviewJournal of Pain and Symptom Management, 2000
- Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scalesPain, 1997
- Impact of nausea/vomiting on quality of life as a visual analogue scale-derived utility scoreSupportive Care in Cancer, 1996
- Treatments for postherpetic neuralgia—a systematic review of randomized controlled trialsFamily Practice, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol®): Double blind crossover trialDiabetologia, 1969